Total Payments
$503,325
2024 Payments
$67,673
Companies
12
Transactions
538
Medicare Patients
1,360
Medicare Billing
$137,215
Payment Breakdown by Category
Other$418,465 (83.1%)
Travel$44,414 (8.8%)
Consulting$27,578 (5.5%)
Food & Beverage$12,853 (2.6%)
Education$14.58 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $408,403 | 136 | 81.1% |
| Travel and Lodging | $44,414 | 203 | 8.8% |
| Consulting Fee | $27,578 | 10 | 5.5% |
| Food and Beverage | $12,853 | 183 | 2.6% |
| Honoraria | $9,562 | 3 | 1.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $500.00 | 1 | 0.1% |
| Education | $14.58 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $290,551 | 362 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $127,307 | 82 | $0 (2024) |
| PFIZER INC. | $63,809 | 68 | $0 (2023) |
| Amgen Inc. | $7,522 | 7 | $0 (2024) |
| Horizon Therapeutics plc | $6,760 | 8 | $0 (2022) |
| IRONWOOD PHARMACEUTICALS, INC | $3,719 | 2 | $0 (2024) |
| Shire North American Group Inc | $2,566 | 2 | $0 (2017) |
| ALCRESTA THERAPEUTICS, INC. | $500.00 | 1 | $0 (2019) |
| GI Supply, Inc. | $250.00 | 1 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $177.14 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67,673 | 51 | Takeda Pharmaceuticals U.S.A., Inc. ($42,598) |
| 2023 | $24,535 | 32 | AbbVie Inc. ($19,020) |
| 2022 | $123,796 | 114 | Takeda Pharmaceuticals U.S.A., Inc. ($80,251) |
| 2021 | $20,055 | 23 | AbbVie Inc. ($13,399) |
| 2020 | $50,617 | 51 | AbbVie Inc. ($36,195) |
| 2019 | $85,654 | 103 | AbbVie, Inc. ($57,385) |
| 2018 | $43,714 | 48 | AbbVie, Inc. ($35,902) |
| 2017 | $87,280 | 116 | AbbVie, Inc. ($84,625) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Travel and Lodging | In-kind items and services | $132.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,875.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $102.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,278.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Travel and Lodging | In-kind items and services | $245.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Travel and Lodging | In-kind items and services | $215.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $107.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,278.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Travel and Lodging | In-kind items and services | $265.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,278.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $109.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $94.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Travel and Lodging | In-kind items and services | $359.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,141.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Amgen Inc. | PROCYSBI (Biological) | Consulting Fee | Cash or cash equivalent | $1,904.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $1,152.56 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $285.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $156.57 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $54.98 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $56.45 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Travel and Lodging | In-kind items and services | $221.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Travel and Lodging | In-kind items and services | $14.40 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 277 | 319 | $170,445 | $28,260 |
| 2022 | 10 | 325 | 381 | $188,479 | $31,231 |
| 2021 | 12 | 349 | 404 | $232,412 | $39,514 |
| 2020 | 14 | 409 | 485 | $269,821 | $38,210 |
Total Patients
1,360
Total Services
1,589
Medicare Billing
$137,215
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 26 | 26 | $39,910 | $5,662 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 50 | 64 | $15,232 | $5,318 | 34.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 28 | 30 | $39,246 | $3,503 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 43 | 49 | $9,163 | $2,482 | 27.1% |
| 44799 | Other procedure on small bowel | Facility | 2023 | 14 | 14 | $22,693 | $2,243 | 9.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 19 | 26 | $6,500 | $1,969 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 16 | $5,360 | $1,829 | 34.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 25 | 30 | $5,250 | $1,579 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $5,991 | $1,491 | 24.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $18,000 | $1,417 | 7.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 27 | 31 | $3,100 | $766.62 | 24.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 38 | 41 | $65,391 | $9,282 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 44 | 56 | $13,328 | $4,560 | 34.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 60 | 80 | $14,000 | $4,123 | 29.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 39 | 40 | $51,898 | $3,061 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 46 | 50 | $9,350 | $2,826 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 19 | $6,365 | $2,317 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $6,797 | $1,622 | 23.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 18 | 25 | $6,250 | $1,429 | 22.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 34 | 43 | $4,300 | $1,074 | 25.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $10,800 | $935.08 | 8.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 47 | 48 | $75,829 | $10,519 | 13.9% |
| 44378 | Control of bleeding of small bowel including lower small intestine (ileum) with biopsies, using an endoscope | Facility | 2021 | 13 | 13 | $30,720 | $4,448 | 14.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 44 | 50 | $11,900 | $4,244 | 35.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 25 | 31 | $10,385 | $3,937 | 37.9% |
About Dr. Adam Stein, M.D
Dr. Adam Stein, M.D is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1962667956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Stein, M.D has received a total of $503,325 in payments from pharmaceutical and medical device companies, with $67,673 received in 2024. These payments were reported across 538 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($408,403).
As a Medicare-enrolled provider, Stein has provided services to 1,360 Medicare beneficiaries, totaling 1,589 services with total Medicare billing of $137,215. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Chicago, IL
- Active Since 07/19/2008
- Last Updated 07/31/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962667956
Products in Payments
- ENTYVIO (Biological) $125,926
- Humira (Biological) $114,358
- XELJANZ (Drug) $63,792
- HUMIRA (Biological) $43,379
- SKYRIZI (Biological) $37,970
- RINVOQ (Biological) $25,012
- PROCYSBI (Biological) $7,522
- PROCYSBI (Drug) $6,760
- GATTEX (Drug) $2,566
- RELIZORB (Device) $500.00
- WALLFLEX (Device) $124.97
- ZEPOSIA (Drug) $116.95
- ACQUIRE (Device) $52.17
- PillCam (Device) $47.58
- Entyvio (Biological) $43.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Myles Wolf, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Robert Kushner, Md, MD
Internal Medicine — Payments: $549,886
Internal Medicine $549,886
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247
Internal Medicine $501,247
Dr. Romeo Ursua, M.d, M.D
Internal Medicine — Payments: $410,468
Internal Medicine $410,468